Cargando…
Evaluation of the Ginsburg Scheme: Where Is Significant Prostate Cancer Missed?
SIMPLE SUMMARY: Systematic biopsy according to the Ginsburg scheme is widely used to complement MRI-targeted biopsy for the diagnosis of prostate cancer. This is the first study to evaluate the distribution of cancerous lesions that were missed by the Ginsburg scheme. We found that significant prost...
Autores principales: | Sigle, August, Jilg, Cordula A., Kuru, Timur H., Binder, Nadine, Michaelis, Jakob, Grabbert, Markus, Schultze-Seemann, Wolfgang, Miernik, Arkadiusz, Gratzke, Christian, Benndorf, Matthias, Suarez-Ibarrola, Rodrigo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8160743/ https://www.ncbi.nlm.nih.gov/pubmed/34065418 http://dx.doi.org/10.3390/cancers13102502 |
Ejemplares similares
-
Comprehensive analysis of complications after transperineal prostate biopsy without antibiotic prophylaxis: results of a multicenter trial with 30 days’ follow-up
por: Kohl, Tobias, et al.
Publicado: (2021) -
Individualized Decision Making in Transperineal Prostate Biopsy: Should All Men Undergo an Additional Systematic Biopsy?
por: Sigle, August, et al.
Publicado: (2022) -
Tyrosine Kinase Inhibitors in the Treatment of Metastasised Renal Cell Carcinoma—Future or the Past?
por: Michaelis, Jakob, et al.
Publicado: (2022) -
(99m)Tc-labelled PSMA ligand for radio-guided surgery in nodal metastatic prostate cancer: proof of principle
por: Mix, Michael, et al.
Publicado: (2021) -
Development and Implementation of an Advanced Program for Robotic Treatment of Prostate Cancer—Is Surgical Quality Transferable?
por: Sigle, August, et al.
Publicado: (2022)